Complete Monthly Cost Analysis: Wegovy vs Mounjaro
Monthly Cost Planning for Wegovy vs Mounjaro Treatment
When comparing Wegovy and Mounjaro monthly costs, understanding the dose escalation timeline is crucial for financial planning. Wegovy follows a structured 16-week escalation starting at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), and £139.99 (1.7mg) before reaching the £209.99 monthly maintenance dose at 2.4mg. This creates predictable monthly expenses that increase gradually as your body adjusts to higher therapeutic doses.
Mounjaro follows a similar escalation pattern but with different dose strengths and corresponding costs, making direct monthly comparisons essential when budgeting for either prescription-only medicine. Both treatments require ongoing monthly investment at maintenance doses, with Wegovy's 2.4mg maintenance representing approximately £2,520 annually at current pricing. Understanding these long-term costs helps patients make informed decisions about their weight management journey alongside their healthcare provider.
Wegovy and Mounjaro Pricing Structure with Discount Codes
EverydayMeds offers competitive pricing for both Wegovy and Mounjaro dose comparisons through our discount code system. New customers benefit from code FIRST40 applied at checkout, bringing Wegovy's starter dose to £79.99 and ensuring the most accessible entry point for either medication. Returning customers maintain excellent value through code DOSE25, keeping ongoing monthly costs predictable throughout their treatment journey.
Our bundle options provide additional convenience for Wegovy dose escalation, with Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) at £169.99 covering your first two months, or the Progress Duo (0.5mg & 1mg) at £189.99 for months two and three. These bundles eliminate the need for monthly reordering during your escalation phase while maintaining transparent pricing for both Wegovy and Mounjaro comparisons.
Clinical Evidence Comparison: Wegovy vs Mounjaro Effectiveness
In clinical trials, Wegovy demonstrated significant weight management results through the STEP programme, with participants achieving approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further showed a 20% reduction in major cardiovascular events, adding clinical value beyond weight management.
Mounjaro's clinical profile stems from its dual-hormone mechanism targeting both GIP and GLP-1 receptors, compared to Wegovy's single GLP-1 approach. Both medications require prescription through clinical assessment and represent evidence-based approaches to weight management when used alongside reduced-calorie diet and increased physical activity, making the monthly cost comparison worthwhile for eligible patients.
How Wegovy Works in Your Monthly Treatment Plan
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. This mechanism works consistently throughout each monthly treatment cycle, with once-weekly injections using the convenient FlexTouch pen system. The gradual dose escalation allows your body to adjust while maintaining therapeutic effect, ensuring each monthly investment contributes to your overall weight management goals. As doses increase monthly from 0.25mg to 2.4mg maintenance, the medication's appetite-suppressing effects typically strengthen, supporting long-term adherence to your reduced-calorie eating plan. Understanding this mechanism helps justify the monthly cost progression and sets realistic expectations for each treatment phase.
Streamlined Ordering for Wegovy and Mounjaro Cost Comparison
EverydayMeds simplifies access to both Wegovy and Mounjaro through our efficient ordering process, starting with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our prescribers review applications within 3 working days (or 24 hours with express service), ensuring clinical appropriateness for either medication. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled cold-chain logistics, maintaining medication integrity from our GPhC-registered pharmacy (#9012878) directly to your door. This process remains consistent whether you're comparing monthly costs for Wegovy or Mounjaro, ensuring reliable access to whichever treatment your prescriber recommends. Payment processing includes automatic application of relevant discount codes, so your quoted monthly costs reflect final pricing without hidden fees.
Storage and Practical Considerations for Monthly Supplies
Wegovy offers practical advantages in storage requirements that impact monthly planning, remaining stable at room temperature for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability provides flexibility for travel and reduces waste if you forget to refrigerate immediately after delivery. Each monthly FlexTouch pen arrives pre-filled and ready to use, eliminating preparation time and ensuring consistent dosing throughout your escalation journey. The once-weekly injection schedule means each monthly supply contains four doses, making it easy to track your progress through each pricing tier. Understanding these practical aspects helps justify the monthly investment in either Wegovy or Mounjaro, as convenience features reduce the complexity of long-term treatment adherence.
Long-term Budget Planning: Wegovy vs Mounjaro Annual Costs
Effective comparison of Wegovy and Mounjaro requires understanding the total annual commitment beyond initial monthly costs. Wegovy's maintenance phase at 2.4mg represents £209.99 monthly, creating an annual investment of approximately £2,520 for ongoing treatment. This calculation assumes consistent maintenance dosing after completing the 16-week escalation, though some patients may require dose adjustments based on clinical response and tolerability. Returning customers benefit from DOSE25 code pricing throughout their maintenance phase, ensuring predictable monthly expenses without unexpected price increases.
Planning for either medication involves considering the escalation period investment versus long-term maintenance costs, with the first four months requiring different monthly budgets before stabilising at maintenance pricing. Both Wegovy and Mounjaro represent significant financial commitments that reflect their prescription-only status and clinical oversight requirements, making cost comparison essential when discussing options with your prescriber. Understanding these annual projections helps patients make informed decisions about sustainable long-term weight management approaches.
Access Your Wegovy or Mounjaro Comparison Today
EverydayMeds provides transparent access to both Wegovy and Mounjaro with clear monthly pricing and no hidden fees, ensuring your cost comparison reflects actual treatment expenses. Our clinical team supports your decision-making process through comprehensive assessment and ongoing prescriber oversight, whether you choose Wegovy's established GLP-1 approach or Mounjaro's dual-hormone mechanism. New customers can begin their cost comparison journey immediately using code FIRST40 at checkout, while returning customers maintain optimal pricing through DOSE25 for consistent monthly budgeting. Both treatments ship with next-day delivery and come with full clinical support throughout your weight management journey. Visit our Wegovy collection at https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and start comparing your monthly treatment options with professional guidance. Our GPhC-registered pharmacy (#9012878) ensures authentic supply and regulatory compliance for whichever prescription-only medicine best suits your clinical needs and budget requirements.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
